LIVN - LivaNova PLC

64.53
-1.280   -1.984%

Share volume: 1,021,126
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$65.81
-1.28
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 14%
Dept financing 18%
Liquidity 17%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.86%
1 Month
2.04%
3 Months
1.02%
6 Months
17.65%
1 Year
81.98%
2 Year
19.48%
Key data
Stock price
$64.53
P/E Ratio 
0.00
DAY RANGE
$64.22 - $67.30
EPS 
-$4.45
52 WEEK RANGE
$35.00 - $71.92
52 WEEK CHANGE
$77.62
MARKET CAP 
3.360 B
YIELD 
N/A
SHARES OUTSTANDING 
54.690 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.92
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$795,941
AVERAGE 30 VOLUME 
$744,576
Company detail
CEO: Damien McDonald
Region: US
Website: livanova.com
Employees: 2,900
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

LivaNova PLC designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The company has a research collaboration with Verily to capture clinical biomarkers of depression.

Recent news